Physician profile
Shane Seipel
NPI 1780117945
$904.01
in general payments reported to CMS, 2019-2025
11 companies · $107 in 2025
The $107 reported for 2025 was less than what a typical Cornea and External Diseases Specialist provider received nationally (typical 2025 total: $477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $84.87 · 2023: $364 · 2024: $348 · 2025: $107.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $819.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $819.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $416.69 | 2022-2025 | Hydrus Microstent, Clareon, Argos |
| Sun Pharmaceutical Industries INC. | $126.73 | 2023-2024 | Cequa |
| Bausch & Lomb Americas INC. | $64.45 | 2022-2025 | Xiidra |
| Tarsus Pharmaceuticals, INC. | $64.08 | 2024 | Xdemvy |
| Dompe US, INC. | $52.31 | 2025 | Oxervate |
| Ocular Therapeutix, INC. | $46.40 | 2023 | Dextenza |
| Abbvie INC. | $44.81 | 2022-2025 | |
| Harrow Eye, LLC | $30.76 | 2024 | Vevye |
| Oyster Point Pharma, INC. | $28.95 | 2022 | |
| Biotissue Holdings INC. | $15.00 | 2024 | |
| Johnson & Johnson Surgical Vision, INC. | $13.83 | 2023 | Tecnis Simplicity, Tecnis Iol, Tecnis Iol |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shane Seipel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.